Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: BIOLAMINA AB
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-18 to 2018-12-31
Current total value of award: $0
Description: ASSORTED CELL CULTURE SUBSTRATES INCLUDING:  HUMAN RECOMBINANT LAMININ-111 HUMAN RECOMBINANT LAMININ-521